Simbrinza
New
Simbrinza
The medicine is intended for the reduction of intraocular pressure in adults ( over 18 years of age) in cases of glaucoma or intraocular hypertension in patients who do not fully respond to treatment for intraocular pressure with a single medicine.
$34.20
